Please login or register first to view this content.
Neurologic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Novel CRISPR Therapy Gets Orphan Drug Status for Transthyretin Amyloidosis
Potential Safety Concern for Guillain-Barré Syndrome ID’d for Ad26.COV2.S
FDA Assigns PDUFA Date for Donepezil Transdermal System
Use of Enzyme-Inducing Antiseizure Meds May Up Long-Term CVD Risk
Gantenerumab Designated Breakthrough Therapy for Alzheimer Disease
Levetiracetam Well Tolerated for Alzheimer Disease
Botulinum Toxin Evaluated for Sialorrhea in Neonates
Ublituximab BLA Submitted for Relapsing Forms of Multiple Sclerosis
Risk for Dementia Not Increased With Menopausal Hormone Therapy
Eisai Begins Rolling BLA Submission of Lecanemab for Early Alzheimer Disease
Ganaxolone Gets Priority Review for CDKL5 Deficiency Disorder
Guillain-Barré Syndrome May Be Triggered by SARS-CoV-2 Infection
Oxcarbazepine Tied to Nontrauma Fracture in Children Aged 4 to 13 With Epilepsy
Traumatic Brain Injury Tied to Later Opioid Use, Misuse
MS Patients Show Robust T-Cell Response to mRNA COVID-19 Vaccines
Most With AD, MCI Would Have Been Excluded From Aducanumab Clinical Trials
Less Screen Time After Concussion Tied to Faster Recovery
Intraperitoneal Therapy Gets Orphan Drug Status for Hyperammonemia
